🟢 Telix Pharmaceuticals is trading 8% up today after announcing a September 22 R&D Day

Telix Pharmaceuticals is trading 8.41% up at $11.53 after announcing its September 22, 2026 R&D Day in New York.

• The event will cover its therapeutic and precision-medicine pipeline, clinical developments, and strategic priorities.
• The announcement appears to have renewed investor attention around Telix Pharmaceuticals’ oncology pipeline.
• No new earnings report or major regulatory approval was announced on August 6, 2026.